A New Ethical Challenge for Institutional Review Boards (IRBs)/Ethics Committees (ECs) in the Assessment of Pediatric Clinical Trials

Both the US and EU have introduced pediatric pharmaceutical legislation to facilitate clinical trials in children and development of better medicines for children. The first concerns were published in 2014 that the European Medicines Agency (EMA)’s Pediatric Committee (PDCO) may be over-enthusiastic...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, Klaus, Kummer, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928761/
https://www.ncbi.nlm.nih.gov/pubmed/27417359
http://dx.doi.org/10.3390/children2020198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928761/
https://www.ncbi.nlm.nih.gov/pubmed/27417359
http://dx.doi.org/10.3390/children2020198

Ejemplares similares